PRAXPraxis Precision Medicines Inc
PRAX
Praxis Precision Medicines Inc1,704
Mkt Cap
$9.77BVolume
116,779.0052W High
$358.7652W Low
$35.21PE Ratio
-26.20PRAX Fundamentals
Price
$345.29Prev Close
$350.56Open
$351.7850D MA
$321.45Beta
0.99Avg. Volume
390,022.20EPS (Annual)
-$13.48P/B
6.93Rev/Employee
$0.00$6,033.81
Moody Aldrich Partners LLC Buys New Position in Praxis Precision Medicines, Inc. $PRAX
Moody Aldrich Partners LLC bought a new stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 41,731 shares of the company's stock, valued a...
Pictet Asset Management Holding SA Makes New $71.09 Million Investment in Praxis Precision Medicines, Inc. $PRAX
Pictet Asset Management Holding SA bought a new position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 240,588 shares of the company's stock, valued at ap...
M&T Bank Corp Purchases Shares of 12,586 Praxis Precision Medicines, Inc. $PRAX
M&T Bank Corp purchased a new position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 12,586 shares of the company's stock, valued at approximately...
Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Praxis Precision Medicines, Inc. $PRAX
Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 37,377 sha...
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) have been assigned an average rating of "Buy" from the twenty analysts that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, one has iss...
Praxis Precision Medicines (PRAX) Projected to Post Earnings on Friday
Praxis Precision Medicines (NASDAQ:PRAX) will be releasing its Q1 2026 earnings before the market opens on Friday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-1-praxis-precision-medicines-inc-stock...
Massachusetts Financial Services Co. MA Purchases New Shares in Praxis Precision Medicines, Inc. $PRAX
Massachusetts Financial Services Co. MA purchased a new stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) in the 4th quarter, according to its most recent 13F filing with the...
Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 5.1% - Time to Sell?
Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 5.1% - Time to Sell...
Praxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC restated a "buy" rating and issued a $510.00 target price on shares of Praxis Precision Medicines in a research note on Tuesday...
Praxis Precision Medicines (NASDAQ:PRAX) Upgraded to Strong-Buy at Raymond James Financial
Raymond James Financial raised Praxis Precision Medicines to a "strong-buy" rating in a report on Thursday...
<
1
2
...
>
Compact View
Not available
Not available